Change and growth in our health care system are driven not only by federal and state regulations and legislation but also by private sector entrepreneurs who strive to expand choice, identify new treatments, and develop cures.
The U.S. bio-pharmaceutical sector is committed to fighting COVID-19, but imposing artificial price controls could impede progress.
This Hill letter was sent to the House Committee on Appropriations, on Fiscal Year 2021 Labor, Health and Human Services, Education, and Related Agencies Appropriations.
This joint letter was sent to the President, Vice President, and Governors Hogan and Cuomo expressing concern for current face covering policies.
Summary of Latest Congressional Action on Coronavirus Response
This Hill letter was sent to the Members of the United States Congress, on a legislative package intended to help American workers and their families weather the coronavirus pandemic.
This Hill letter was sent to the Members of the United States Congress, on legislation to address the coronavirus pandemic.
This Hill letter was sent to the members of the United States Congress, supporting H.R. 6074, the "Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020."
This Hill letter was sent to Senator Mike Crapo and to Members of the United States Senate, supporting S. 3129, the "Lower Costs, More Cures Act of 2019."
From shipping to staffing, the Chamber and its partners have the tools to save your business money and the solutions to help you run it more efficiently. Join the U.S. Chamber of Commerce today to start saving.
Weekly insights and analysis from the intersection of government and business.
